Uveitis: Medico-economical and Clinical Evaluation of a Standardized Strategy for an Etiological Diagnosis
- Patient consulting one of the study's sites
- Age > 18 years old
- Affiliation to the French national health insurance program
- Patient agreeing to participate in the study
- Positive HIV serology
- Postsurgical or posttraumatic uveitis or endophthalmitis
- Toxoplasmic uveitis
- Pathology likely to be the cause of the known uveitis
- Ophthalmic entities only diagnosed by the ophthalmic examination
- Age < 18 years old
- Patient under law protection or guardianship
- Pregnant women or those planning to be pregnant during the study
- Severe uveitis (VA < 20/200) with retinal vascularitis requiring an emergency
treatment and assessment.
Type of Study:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
The primary outcome is the percentage of patients having an etiological diagnosis 6 months after the beginning of the study for both strategies.
Note: Only diagnoses made at the end of the standardized strategy will be numbered in this arm of the study; all diagnoses made after by the free authorized examinations in this same arm will lead to standardized strategy failure.
Outcome Time Frame:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
- etiological diagnosis
- standardized strategy